mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
2e-05 |
mRNA |
serdemetan:SCH-529074 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-05 |
mRNA |
Crizotinib |
CCLE |
pan-cancer |
AAC |
0.2 |
6e-05 |
mRNA |
BRD-K49290616 |
CTRPv2 |
pan-cancer |
AAC |
0.3 |
0.0002 |
mRNA |
Rapamycin |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0007 |
mRNA |
neratinib |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.001 |
mRNA |
BRD-K45681478 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.001 |
mRNA |
austocystin d |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.002 |
mRNA |
Compound 7d-cis |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.002 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |